Cargando…
Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression
Microbiome is now considered as a significant metabolic organ with an immense potential to influence overall human health. A number of diseases that are associated with pharmacotherapy interventions was linked with altered gut microbiota. Moreover, it has been reported earlier that gut microbiome mo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577747/ https://www.ncbi.nlm.nih.gov/pubmed/34752478 http://dx.doi.org/10.1371/journal.pone.0259643 |
_version_ | 1784596123177975808 |
---|---|
author | Zemanová, Nina Lněničková, Kateřina Vavrečková, Markéta Anzenbacherová, Eva Anzenbacher, Pavel Zapletalová, Iveta Hermanová, Petra Hudcovic, Tomáš Kozáková, Hana Jourová, Lenka |
author_facet | Zemanová, Nina Lněničková, Kateřina Vavrečková, Markéta Anzenbacherová, Eva Anzenbacher, Pavel Zapletalová, Iveta Hermanová, Petra Hudcovic, Tomáš Kozáková, Hana Jourová, Lenka |
author_sort | Zemanová, Nina |
collection | PubMed |
description | Microbiome is now considered as a significant metabolic organ with an immense potential to influence overall human health. A number of diseases that are associated with pharmacotherapy interventions was linked with altered gut microbiota. Moreover, it has been reported earlier that gut microbiome modulates the fate of more than 30 commonly used drugs and, vice versa, drugs have been shown to affect the composition of the gut microbiome. The molecular mechanisms of this mutual relationship, however, remain mostly elusive. Recent studies indicate an indirect effect of the gut microbiome through its metabolites on the expression of biotransformation enzymes in the liver. The aim of this study was to analyse the effect of gut microbiome on the fate of metronidazole in the mice through modulation of system of drug metabolizing enzymes, namely by alteration of the expression and activity of selected cytochromes P450 (CYPs). To assess the influence of gut microbiome, germ-free mice (GF) in comparison to control specific-pathogen-free (SPF) mice were used. First, it has been found that the absence of microbiota significantly affected plasma concentration of metronidazole, resulting in higher levels (by 30%) of the parent drug in murine plasma of GF mice. Further, the significant interaction between presence/absence of the gut microbiome and effect of metronidazole application, which together influence mRNA expression of CAR, PPARα, Cyp2b10 and Cyp2c38 was determined. Administration of metronidazole itself influenced significantly mRNA expression of Cyp1a2, Cyp2b10, Cyp2c38 and Cyp2d22. Finally, GF mice have shown lower level of enzyme activity of CYP2A and CYP3A than their SPF counterparts. The results hence have shown that, beside direct bacterial metabolism, different expression and enzyme activity of hepatic CYPs in the presence/absence of gut microbiota may be responsible for the altered metronidazole metabolism. |
format | Online Article Text |
id | pubmed-8577747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-85777472021-11-10 Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression Zemanová, Nina Lněničková, Kateřina Vavrečková, Markéta Anzenbacherová, Eva Anzenbacher, Pavel Zapletalová, Iveta Hermanová, Petra Hudcovic, Tomáš Kozáková, Hana Jourová, Lenka PLoS One Research Article Microbiome is now considered as a significant metabolic organ with an immense potential to influence overall human health. A number of diseases that are associated with pharmacotherapy interventions was linked with altered gut microbiota. Moreover, it has been reported earlier that gut microbiome modulates the fate of more than 30 commonly used drugs and, vice versa, drugs have been shown to affect the composition of the gut microbiome. The molecular mechanisms of this mutual relationship, however, remain mostly elusive. Recent studies indicate an indirect effect of the gut microbiome through its metabolites on the expression of biotransformation enzymes in the liver. The aim of this study was to analyse the effect of gut microbiome on the fate of metronidazole in the mice through modulation of system of drug metabolizing enzymes, namely by alteration of the expression and activity of selected cytochromes P450 (CYPs). To assess the influence of gut microbiome, germ-free mice (GF) in comparison to control specific-pathogen-free (SPF) mice were used. First, it has been found that the absence of microbiota significantly affected plasma concentration of metronidazole, resulting in higher levels (by 30%) of the parent drug in murine plasma of GF mice. Further, the significant interaction between presence/absence of the gut microbiome and effect of metronidazole application, which together influence mRNA expression of CAR, PPARα, Cyp2b10 and Cyp2c38 was determined. Administration of metronidazole itself influenced significantly mRNA expression of Cyp1a2, Cyp2b10, Cyp2c38 and Cyp2d22. Finally, GF mice have shown lower level of enzyme activity of CYP2A and CYP3A than their SPF counterparts. The results hence have shown that, beside direct bacterial metabolism, different expression and enzyme activity of hepatic CYPs in the presence/absence of gut microbiota may be responsible for the altered metronidazole metabolism. Public Library of Science 2021-11-09 /pmc/articles/PMC8577747/ /pubmed/34752478 http://dx.doi.org/10.1371/journal.pone.0259643 Text en © 2021 Zemanová et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Zemanová, Nina Lněničková, Kateřina Vavrečková, Markéta Anzenbacherová, Eva Anzenbacher, Pavel Zapletalová, Iveta Hermanová, Petra Hudcovic, Tomáš Kozáková, Hana Jourová, Lenka Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression |
title | Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression |
title_full | Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression |
title_fullStr | Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression |
title_full_unstemmed | Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression |
title_short | Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression |
title_sort | gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes p450 expression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577747/ https://www.ncbi.nlm.nih.gov/pubmed/34752478 http://dx.doi.org/10.1371/journal.pone.0259643 |
work_keys_str_mv | AT zemanovanina gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT lnenickovakaterina gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT vavreckovamarketa gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT anzenbacherovaeva gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT anzenbacherpavel gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT zapletalovaiveta gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT hermanovapetra gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT hudcovictomas gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT kozakovahana gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression AT jourovalenka gutmicrobiomeaffectsthemetabolismofmetronidazoleinmicethroughregulationofhepaticcytochromesp450expression |